<DOC>
	<DOCNO>NCT00351585</DOCNO>
	<brief_summary>Type 2 diabetes result body produce enough insulin regulate blood sugar . This study design measure effect vildagliptin maximum insulin secretion pancreas .</brief_summary>
	<brief_title>A Study Evaluate Effect Vildagliptin Maximum Insulin Secretion Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diagnosed type 2 diabetes least 6 month Patients whose diabetes control diet exercise patient take metformin BMI range 2245 Blood glucose criterion must meet Pregnancy lactation Type 1 diabetes diabetes result pancreatic injury Cardiovascular complication define protocol Significant diabetic complication define protocol Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Vildagliptin</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Insulin secretion</keyword>
	<keyword>Beta cell</keyword>
</DOC>